GI cancer

February 24, 2022

Trial Spotlight: Nataliya Uboha on the EA2183 Trial for Esophageal and Gastric Adenocarcinoma

This randomized phase III trial explores the addition of radiotherapy to the usual treatment (chemotherapy) in patients with esophagus and stomach cancer with limited spread
January 25, 2021

Now Enrolling: EA2197 / OPT-IN for Gallbladder Cancer

This phase II/III study, led by Dr. Shishir Maithel, is assessing the role of neoadjuvant therapy for patients with incidental gallbladder cancer
December 14, 2020

Reopened Trial: Jennifer Eads, MD on Study EA2174 for Esophageal and Gastroesophageal Cancer

EA2174 will evaluate the role of perioperative immunotherapy for patients with esophageal or gastroesophageal junction adenocarcinoma